-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
KalVista Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate for Q4 2016.
- KalVista Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending January 31, 2017 was $0.000.
- KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
- KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)